| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.16 | 2e-06 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | 0.19 | 6e-06 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.2 | 4e-05 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.13 | 6e-05 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | 0.19 | 7e-05 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.0001 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | -0.19 | 0.0002 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.18 | 0.0002 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0002 |